These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1036972)
21. Qualitative and quantitative changes of nucleoli in lymphocytes of cancer patients during cytembena or cyclophosphamide therapy. Matĕjková E; Vlastiborová A Neoplasma; 1973 May; 20(5):517-23. PubMed ID: 4800661 [No Abstract] [Full Text] [Related]
22. Preliminary results with the new cytostatic Penberol in ovarian carcinoma. Novotná J; Andrysek O Neoplasma; 1980; 27(1):77-82. PubMed ID: 7374860 [TBL] [Abstract][Full Text] [Related]
30. [New developments in the chemotherapy of ovarian cancer (author's transl)]. Brunner KW; Goldhirsch A; Joss R Schweiz Rundsch Med Prax; 1981 Apr; 70(18):809-14. PubMed ID: 7243721 [No Abstract] [Full Text] [Related]
31. [Results obtained with chemotherapy of endometrial cancer (author's transl)]. Chmelík V; Dvorák O Cesk Gynekol; 1976 Dec; 41(10):727-8. PubMed ID: 1036974 [No Abstract] [Full Text] [Related]
32. Advanced ovarian cancer: therapy with radiation and cyclophosphamide in a random series. Johnson CE; Decker DG; Van Herik M; Mussey E; Malkasian GD; Jorgensen EO Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):136-41. PubMed ID: 4550548 [No Abstract] [Full Text] [Related]
36. [Report on the management of advanced ovarian cancer using Endoxan (Asta) and cyclophosphamide preparations]. Dvorák O; Spirová M Zentralbl Gynakol; 1967 Jul; 89(26):940-5. PubMed ID: 5587033 [No Abstract] [Full Text] [Related]
37. Management of ovarian cancer in the renal transplant recipient with cyclophosphamide used as an immunosuppressive and antineoplastic agent. Vincent F; Michel M; Marrast AC; Bensousan TA; Glotz D; Duboust A Transplant Proc; 1995 Aug; 27(4):2432. PubMed ID: 7652865 [No Abstract] [Full Text] [Related]
38. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer. Barlow JJ; Piver MS Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714 [TBL] [Abstract][Full Text] [Related]
39. [Chemotherapeutic treatment of advanced ovarian carcinoma. Preliminary results of the Piedmont-Liguria Cooperative Group]. Conte PF; Rosso R; Bruzzone M; Sertoli MR; Rubagotti A; Santi L; Carnino F; Cottini M; Mossetti C; Gatti M Minerva Ginecol; 1984 Apr; 36(4):213-6. PubMed ID: 6547773 [No Abstract] [Full Text] [Related]
40. [Determination of the nucleolar coefficient in lymphocytes in chemotherapeutically treated patients with ovarian carcinoma]. Jandrová A; Laurová L; Skoda V; Trnka V Zentralbl Bakteriol Orig B; 1975; 91(9):549-51. PubMed ID: 1189808 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]